Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

104.04

+1.62 (1.58%)

Aug 25, 2026, 11:11 AM EDT - Market open

Oruka Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-155.08	-122.05	-95.26
Net Income	-109.69	-84.31	-70.95
Earnings Per Share	-2.02	-1.85	-4.23
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,126	479.58	393.72
Total Debt	2.55	1.93	0.97
Net Cash (Debt)	1,123	477.65	392.75
Net Cash Growth	221.66%	21.62%	-
Net Cash Per Share	20.72	10.47	23.39

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-100.92	-88.21	-63.09
Capital Expenditures	-0.24	-0.21	-0.21
Free Cash Flow	-101.15	-88.42	-63.3
Free Cash Flow Growth	-	-	-

Valuation

Selected indicators aren't available for this stock.